Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma

This billing and coding guidance requires specific claim elements for molecular biomarker testing for risk stratification of cutaneous squamous cell carcinoma: an appropriate CPT code with 1 unit of service, the correct DEX Z-Code placed in the specified Part A/Part B fields, and an appropriate ICD-10-CM diagnosis code. Failure to enter the DEX Z-Code in the exact required field or format, or omission of any required element, may result in claim denial; clinical coverage criteria are defined in MolDX LCD L39585.

"Clinical coverage criteria are defined in the referenced MolDX LCD L39585; follow that LCD for patient eligibility and medical indications for molecular biomarker testing for cutaneous squamous cel..."

Sign up to see full coverage criteria, indications, and limitations.